These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1557940)

  • 1. Effects of nitrates on splanchnic and hepatic circulation.
    Irestedt L
    Acta Anaesthesiol Scand Suppl; 1992; 97():31-3. PubMed ID: 1557940
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato-splanchnic blood flow.
    Wisén E; Svennerholm K; Bown LS; Houltz E; Rizell M; Lundin S; Ricksten SE
    Acta Anaesthesiol Scand; 2018 Aug; 62(7):953-961. PubMed ID: 29578250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis.
    Iwao T; Toyonaga A; Sumino M; Takagi K; Ohkubo K; Inoue R; Tanikawa K
    Hepatology; 1991 Jan; 13(1):124-8. PubMed ID: 1899080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation versus intravenous anaesthesia. Effects on the hepatic and splanchnic circulation.
    Andreen M
    Acta Anaesthesiol Scand Suppl; 1982; 75():25-31. PubMed ID: 6753444
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitroglycerin for portal hypertension. A controlled comparison of the hemodynamic effects of graded doses.
    Rector WG; Hossack KF; Ready JB
    J Hepatol; 1990 May; 10(3):375-80. PubMed ID: 2114438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
    Van de Casteele M; Hösli M; Sägesser H; Reichen J
    J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of nitroglycerin and long-acting nitrates.
    Abrams J
    Am Heart J; 1985 Jul; 110(1 Pt 2):216-24. PubMed ID: 3925741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
    Kakumitsu S; Shijo H; Yokoyama M; Kim T; Akiyoshi N; Ota K; Kubara K; Okumura M; Inoue K
    Hepatology; 1998 Feb; 27(2):377-82. PubMed ID: 9462634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nitroglycerin on splanchnic capacity and splanchnic capacity-cardiac output relationship.
    Morse MA; Rutlen DL
    J Appl Physiol (1985); 1994 Jan; 76(1):112-9. PubMed ID: 8175494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
    Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
    Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver.
    Slehria S; Rajvanshi P; Ito Y; Sokhi RP; Bhargava KK; Palestro CJ; McCuskey RS; Gupta S
    Hepatology; 2002 Jun; 35(6):1320-8. PubMed ID: 12029617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of sevoflurane on the area of the liver and spleen].
    Schindler E; Hempelmann G
    Anaesthesist; 1996 Feb; 45 Suppl 1():S29-31. PubMed ID: 8775100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostaglandin E1 and nitroglycerin on portal venous flow during hypothermic extracorporeal circulation: assessment by transesophageal echography.
    Iribe G; Ohnishi Y; Hayashi Y; Kuro M
    Acta Anaesthesiol Scand; 1999 May; 43(5):520-5. PubMed ID: 10341999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vaso-active agents on hepatic function and blood gases in patients with cirrhosis: a study of vasopressin and nitroglycerin.
    Iwao T; Toyonaga A; Sumino M; Takagi K; Oho K; Ohkubo K; Inoue R; Tanikawa K
    J Gastroenterol Hepatol; 1992; 7(2):148-53. PubMed ID: 1571496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension.
    Tsai HC; Li TH; Huang CC; Huang SF; Liu RS; Yang YY; Hsieh YC; Lee KC; Huang YH; Hou MC; Lin HC
    Am J Pathol; 2018 Jul; 188(7):1608-1624. PubMed ID: 29929914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and splanchnic metabolic response to exogenous human growth hormone.
    Dahn MS; Lange MP
    Surgery; 1998 May; 123(5):528-38. PubMed ID: 9591005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-conventional vasopressors in septic shock: effects on hepatosplanchnic blood flow.
    Takala J
    Schweiz Med Wochenschr; 2000 Dec; 130(50):1937-41. PubMed ID: 11189439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective gastrointestinal circulatory changes due to a vasopressin hormonogen in the cat.
    Greenstein RJ; Dreiling DA
    Mt Sinai J Med; 1983; 50(6):498-500. PubMed ID: 6607405
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of deliberate hypotension on splanchnic perfusion balance with use of either isoflurane or esmolol and nitroglycerin.
    Andel D; Andel H; Hörauf K; Felfernig D; Millesi W; Zimpfer M
    Anesth Analg; 2001 Nov; 93(5):1116-20. PubMed ID: 11682378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.